These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 112132)

  • 21. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM
    Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
    García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
    Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Isoenzymes of melanosomal tyrosinase isolated from transplanted hamster melanomas].
    Blagoeva PM; Ivanova TsIa
    Biokhimiia; 1984 May; 49(5):804-6. PubMed ID: 6430355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosinase isolated from mouse melanoma melanosome.
    Miyazaki K; Seiji M
    J Invest Dermatol; 1971 Aug; 57(2):81-6. PubMed ID: 4999637
    [No Abstract]   [Full Text] [Related]  

  • 26. Mammalian tyrosinase. Structural and functional interraltionship of isozymes.
    Hearing VJ; Nicholson JM; Montague PM; Ekel TM; Tomecki KJ
    Biochim Biophys Acta; 1978 Feb; 522(2):327-39. PubMed ID: 414782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed.
    Hearing VJ
    Methods Enzymol; 1987; 142():154-65. PubMed ID: 3110555
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
    Wrathall JR; Oliver C; Silagi S; Essner E
    J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heterogeneity of mammalian tyrosinases].
    Pavel S; Vachtenheim J
    Cesk Fysiol; 1979; 28(6):491-505. PubMed ID: 117908
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with elevated tyrosinase activity.
    Bomirski A; Wrzołkowa T; Arendarczyk M; Bomirska M; Kuklinska E; Słominski A; Moellmann G
    J Invest Dermatol; 1987 Nov; 89(5):469-73. PubMed ID: 3117904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
    Imokawa G; Mishima Y
    Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histochemical quantification of dopa-oxidase (tyrosinase) activity in epidermal melanocytes.
    Sasai Y; Kumano S; Takahashi M; Nakano H
    Histochemistry; 1978 Apr; 55(3):235-43. PubMed ID: 417051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of mouse tyrosinase by enzyme-linked immunosorbent assay.
    Ishiguro S; Yamamoto H; Yanai N; Takeuchi T
    J Biochem; 1986 Apr; 99(4):1081-5. PubMed ID: 3086301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
    Edelstein LM; Cariglia N; Okun MR; Patel RP; Smucker D
    J Invest Dermatol; 1975 May; 64(5):364-70. PubMed ID: 806638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of x-irradiation on melanosomal tyrosinase activity.
    Van Woert MH; Korb F
    Radiat Res; 1973 Mar; 53(3):435-43. PubMed ID: 4633182
    [No Abstract]   [Full Text] [Related]  

  • 36. Hazard in tyrosinase assays.
    Bennett DC
    J Invest Dermatol; 1989 Nov; 93(5):709. PubMed ID: 2507646
    [No Abstract]   [Full Text] [Related]  

  • 37. The subcellular distribution of lysosomal hydrolases in the Harding-Passey melanoma.
    Mufson RA
    J Cell Physiol; 1974 Feb; 83(1):75-83. PubMed ID: 4204977
    [No Abstract]   [Full Text] [Related]  

  • 38. A rapid method for detection of tyrosinase activity in electrophoresis.
    Nellaiappan K; Vinayagam A
    Stain Technol; 1986 Sep; 61(5):269-72. PubMed ID: 3097880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
    Nishioka K
    FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma.
    Shibata T; Pavel S; Smit NP; Mishima Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):222S-225S. PubMed ID: 8433011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.